Cargando…

Protein engineering to develop a redox insensitive endothelial nitric oxide synthase()

The zinc tetrathiolate (ZnS(4)) cluster is an important structural feature of endothelial nitric oxide synthase (eNOS). The cluster is located on the dimeric interface and four cysteine residues (C94 and C99 from two adjacent subunits) form a cluster with a Zn ion in the center of a tetrahedral conf...

Descripción completa

Detalles Bibliográficos
Autores principales: Rafikov, Ruslan, Kumar, Sanjiv, Aggarwal, Saurabh, Pardo, Daniel, Fonseca, Fabio V., Ransom, Jessica, Rafikova, Olga, Chen, Qiumei, Springer, Matthew L., Black, Stephen M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4297941/
https://www.ncbi.nlm.nih.gov/pubmed/25460726
http://dx.doi.org/10.1016/j.redox.2013.12.015
Descripción
Sumario:The zinc tetrathiolate (ZnS(4)) cluster is an important structural feature of endothelial nitric oxide synthase (eNOS). The cluster is located on the dimeric interface and four cysteine residues (C94 and C99 from two adjacent subunits) form a cluster with a Zn ion in the center of a tetrahedral configuration. Due to its high sensitivity to oxidants this cluster is responsible for eNOS dimer destabilization during periods of redox stress. In this work we utilized site directed mutagenesis to replace the redox sensitive cysteine residues in the ZnS(4) cluster with redox stable tetra-arginines. Our data indicate that this C94R/C99R eNOS mutant is active. In addition, this mutant protein is insensitive to dimer disruption and inhibition when challenged with hydrogen peroxide (H(2)O(2)). Further, the overexpression of the C94R/C99R mutant preserved the angiogenic response in endothelial cells challenged with H(2)O(2). The over-expression of the C94R/C99R mutant preserved the ability of endothelial cells to migrate towards vascular endothelial growth factor (VEGF) and preserved the endothelial monolayer in a scratch wound assay. We propose that this dimer stable eNOS mutant could be utilized in the treatment of diseases in which there is eNOS dysfunction due to high levels of oxidative stress.